Market Research Life Sciences Market Research Medical Devices Market Research Wound Care Market Research Closures Market Research

Chronic Wound Care Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Best Price Guarantee Length Publisher Published Date SKU
from $4,850 160 Pages Fortune Business Insights Pvt. Ltd. April, 2024 FOB18772805
Best Price Guarantee
Price from $4,850
Length 160 Pages
Publisher Fortune Business Insights Pvt. Ltd.
Published Date April, 2024
SKU FOB18772805

Chronic Wound Care Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032



Growth Factors of Chronic Wound Care Market


The chronic wound care market size was valued at USD 13.29 billion in 2023, and the market is now projected to grow from USD 14.17 billion in 2024 to USD 24.03 billion by 2032, exhibiting a CAGR of 6.8% during the forecast period of 2024-2032.

The COVID-19 widespread adversely affected a few medical device segments due to decrease of non-essential methods and healthcare administrations. This figure resulted within the exclusion of wound care from the fundamental strategies list and has been considered an elective strategy in most countries.

The rising predominance of diabetic ulcers, pressure ulcers, and others is anticipated to extend the demand for dressings, devices, and dynamic treatments to treat these wounds. Moreover, pressure ulcers are one of the driving causes of constant wounds. Subsequently, the expanding predominance of different sorts of incessant wounds all inclusive is creating a high demand for treatment items and, subsequently, fueling the appropriation of wound dressings, gadgets, and other items amid the estimate period and fueling the chronic wound care market growth.

A few market players and research organizations are continually centering on the dynamic treatment section due to the expanding application of bioactive treatments such as bioequivalent and skin graft in treating these wounds.

Comprehensive Analysis Of Chronic Wound Care Market

The market is segmented into diabetic ulcers, pressure ulcers, venous leg ulcers, and others in terms of type. The biggest chronic wound care market share was captured by the diabetic ulcers section. Based on product, the market is segmented into advanced wound dressings, wound care gadgets, active therapy, and others. Advanced wound dressings product segment accounted for a dominant market share. Based on end user, the market is fragmented into hospitals & wound clinics and home care settings & others. The healing centers & wound clinics fragment is expected to dominate the market amid the estimate period.

The chronic wound care market share in North America stood at USD 4.98 billion in 2023. The dominance of this region is inferable to the developing predominance of chronic wounds, higher cost of treatment, and presence of adequate reimbursement policies within the U.S and Canada.

The top players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players listed as: Smith & Nephew (U.K.), Mölnlycke Health Care AB (Sweden), 3M (U.S.), ConvaTec Group PLC (U.K.), Tissue Regenix (U.S.), B. Braun Melsungen AG (Germany), Integra LifeSciences Corporation (U.S.), Coloplast Corp (Denmark), Cardinal Health (U.S.), MiMedx (U.S.).

In January 2023 the company Mimedx entered into an exclusive dispersion agreement with Gunze Therapeutic Restricted to offer placental tissue allograft, Epifix for wound healing in Japan. Upon this agreement, the company points at fortifying its position in the Japan market.

Segmentation Table

Attribute Details

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 6.8% from 2024-2032

Unit Value (USD billion)

Segmentation

By Type

Diabetic Ulcers

Pressure Ulcers

Venous Leg Ulcers

Others

By Product

Advanced Wound Dressings

Wound Care Devices

Active Therapy

Others

By End User

Hospitals & Wound Clinics

Homecare Settings & Others

By Region

North America (By Type, By Product, By End User, and By Country)

-U.S. (By Type)

-Canada (By Type)

Europe (By Type, By Product, By End User, and By Country)

-Germany (By Type)

-U.K. (By Type)

-France (By Type)

-Italy (By Type)

-Spain (By Type)

-Scandinavia (By Type)

-Rest of Europe (By Type)

Asia Pacific (By Type, By Product, By End User, and By Country)

-Japan (By Type)

-China (By Type)

-India (By Type)

-Australia (By Type)

-Southeast Asia (By Type)

-Rest of Asia Pacific (By Type)

Latin America (By Type, By Product, By End User, and By Country)

-Brazil (By Type)

-Mexico (By Type)

-Rest of Latin America (By Type)

Middle East & Africa (By Type, By Product, By End User, and By Country)

-GCC (By Type)

-South Africa (By Type)

-Rest of Middle East & Africa (By Type)


1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Prevalence of Key Chronic Wounds, Key Countries/Region, 2022/2023
4.2. New Product Launches, By Key Players
4.3. Key Industry Developments (Mergers, Acquisitions, etc.)
4.4. Impact of COVID-19 on the Global Chronic Wound Care Market
5. Global Chronic Wound Care Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Type
5.1.1. Diabetic Ulcers
5.1.2. Pressure Ulcers
5.1.3. Venous Ulcers
5.1.4. Others
5.2. Market Analysis, Insights and Forecast – By Product
5.2.1. Advanced Wound Dressings
5.2.2. Wound Care Devices
5.2.3. Active Therapy
5.2.4. Others
5.3. Market Analysis, Insights and Forecast – By End User
5.3.1. Hospitals & Wound Care Centers
5.3.2. Homecare Settings & Others
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East & Africa
6. North America Chronic Wound Care Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Type
6.1.1. Diabetic Ulcers
6.1.2. Pressure Ulcers
6.1.3. Venous Ulcers
6.1.4. Others
6.2. Market Analysis, Insights and Forecast – By Product
6.2.1. Advanced Wound Dressings
6.2.2. Wound Care Devices
6.2.3. Active Therapy
6.2.4. Others
6.3. Market Analysis, Insights and Forecast – By End User
6.3.1. Hospitals & Wound Care Centers
6.3.2. Homecare Settings & Others
6.4. Market Analysis, Insights and Forecast – By Country
6.4.1. U.S.
6.4.1.1. By Type
6.4.2. Canada
6.4.2.1. By Type
7. Europe Chronic Wound Care Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Type
7.1.1. Diabetic Ulcers
7.1.2. Pressure Ulcers
7.1.3. Venous Ulcers
7.1.4. Others
7.2. Market Analysis, Insights and Forecast – By Product
7.2.1. Advanced Wound Dressings
7.2.2. Wound Care Devices
7.2.3. Active Therapy
7.2.4. Others
7.3. Market Analysis, Insights and Forecast – By End User
7.3.1. Hospitals & Wound Care Centers
7.3.2. Homecare Settings & Others
7.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
7.4.1. U.K.
7.4.1.1. By Type
7.4.2. Germany
7.4.2.1. By Type
7.4.3. France
7.4.3.1. By Type
7.4.4. Spain
7.4.4.1. By Type
7.4.5. Italy
7.4.5.1. By Type
7.4.6. Scandinavia
7.4.6.1. By Type
7.4.7. Rest of Europe
7.4.7.1. By Type
8. Asia Pacific Chronic Wound Care Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Type
8.1.1. Diabetic Ulcers
8.1.2. Pressure Ulcers
8.1.3. Venous Ulcers
8.1.4. Others
8.2. Market Analysis, Insights and Forecast – By Product
8.2.1. Advanced Wound Dressings
8.2.2. Wound Care Devices
8.2.3. Active Therapy
8.2.4. Others
8.3. Market Analysis, Insights and Forecast – By End User
8.3.1. Hospitals & Wound Care Centers
8.3.2. Homecare Settings & Others
8.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
8.4.1. Japan
8.4.1.1. By Type
8.4.2. China
8.4.2.1. By Type
8.4.3. India
8.4.3.1. By Type
8.4.4. Australia
8.4.4.1. By Type
8.4.5. Southeast Asia
8.4.5.1. By Type
8.4.6. Rest of Asia Pacific
8.4.6.1. By Type
9. Latin America Chronic Wound Care Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Type
9.1.1. Diabetic Ulcers
9.1.2. Pressure Ulcers
9.1.3. Venous Ulcers
9.1.4. Others
9.2. Market Analysis, Insights and Forecast – By Product
9.2.1. Advanced Wound Dressings
9.2.2. Wound Care Devices
9.2.3. Active Therapy
9.2.4. Others
9.3. Market Analysis, Insights and Forecast – By End User
9.3.1. Hospitals & Wound Care Centers
9.3.2. Homecare Settings & Others
9.4. Market Analysis, Insights and Forecast – By Country
9.4.1. Brazil
9.4.1.1. By Type
9.4.2. Mexico
9.4.2.1. By Type
9.4.3. Rest of Latin America
9.4.3.1. By Type
10. Middle East & Africa Chronic Wound Care Market Analysis, Insights and Forecast, 2019-2032
10.1. Market Analysis, Insights and Forecast – By Type
10.1.1. Diabetic Ulcers
10.1.2. Pressure Ulcers
10.1.3. Venous Ulcers
10.1.4. Others
10.2. Market Analysis, Insights and Forecast – By Product
10.2.1. Advanced Wound Dressings
10.2.2. Wound Care Devices
10.2.3. Active Therapy
10.2.4. Others
10.3. Market Analysis, Insights and Forecast – By End User
10.3.1. Hospitals & Wound Care Centers
10.3.2. Homecare Settings & Others
10.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
10.4.1. GCC
10.4.1.1. By Type
10.4.2. South Africa
10.4.2.1. By Type
10.4.3. Rest of Middle East & Africa
10.4.3.1. By Type
11. Competitive Analysis
11.1. Global Market Share Analysis (2023)
11.2. Company Profiles
11.2.1. Smith & Nephew
11.2.1.1. Overview
11.2.1.2. Products
11.2.1.3. SWOT Analysis
11.2.1.4. Recent Developments
11.2.1.5. Strategies
11.2.1.6. Financials (Based on Availability)
11.2.2. Mölnlycke Health Care AB
11.2.2.1. Overview
11.2.2.2. Products
11.2.2.3. SWOT Analysis
11.2.2.4. Recent Developments
11.2.2.5. Strategies
11.2.2.6. Financials (Based on Availability)
11.2.3. 3M
11.2.3.1. Overview
11.2.3.2. Products
11.2.3.3. SWOT Analysis
11.2.3.4. Recent Developments
11.2.3.5. Strategies
11.2.3.6. Financials (Based on Availability)
11.2.4. ConvaTec Inc.
11.2.4.1. Overview
11.2.4.2. Products
11.2.4.3. SWOT Analysis
11.2.4.4. Recent Developments
11.2.4.5. Strategies
11.2.4.6. Financials (Based on Availability)
11.2.5. Tissue Regenix
11.2.5.1. Overview
11.2.5.2. Products
11.2.5.3. SWOT Analysis
11.2.5.4. Recent Developments
11.2.5.5. Strategies
11.2.5.6. Financials (Based on Availability)
11.2.6. B. Braun Melsungen AG
11.2.6.1. Overview
11.2.6.2. Products
11.2.6.3. SWOT Analysis
11.2.6.4. Recent Developments
11.2.6.5. Strategies
11.2.6.6. Financials (Based on Availability)
11.2.7. Integra LifeSciences Corporation
11.2.7.1. Overview
11.2.7.2. Products
11.2.7.3. SWOT Analysis
11.2.7.4. Recent Developments
11.2.7.5. Strategies
11.2.7.6. Financials (Based on Availability)
11.2.8. Coloplast Corp
11.2.8.1. Overview
11.2.8.2. Products
11.2.8.3. SWOT Analysis
11.2.8.4. Recent Developments
11.2.8.5. Strategies
11.2.8.6. Financials (Based on Availability)
11.2.9. Cardinal Health
11.2.9.1. Overview
11.2.9.2. Products
11.2.9.3. SWOT Analysis
11.2.9.4. Recent Developments
11.2.9.5. Strategies
11.2.9.6. Financials (Based on Availability)
11.2.10. MiMedx Group
11.2.10.1. Overview
11.2.10.2. Products
11.2.10.3. SWOT Analysis
11.2.10.4. Recent Developments
11.2.10.5. Strategies
11.2.10.6. Financials (Based on Availability)
11.2.11. Triad Life Sciences, Inc.
11.2.11.1. Overview
11.2.11.2. Products
11.2.11.3. SWOT Analysis
11.2.11.4. Recent Developments
11.2.11.5. Strategies
11.2.11.6. Financials (Based on Availability)

$4,850
$6,850

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings